Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation

Clinical trial NCT07354477 · RECRUITING

Trial details

NCT number: NCT07354477
Sponsor: Qlaris Bio, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-proliferative Diabetic Retinopathy (NPDR)Open-angle Glaucoma (OAG)Normal Tension Glaucoma (NTG)

Start date: 2026-02-20
Primary completion: 2026-09-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.